Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to procedures for the alternative assessment or exemption from assessment of certain public school students who receive special education services and alternative accountability plans for certain campuses serving students who receive special education services.
Relating to permissible accountability interventions for certain school districts with low-performing campuses.
Relating to the behavioral management of a student enrolled in a special education program of a school district.
Relating to applications for the establishment of certain new open-enrollment charter school campuses.
Relating to the use of glucagon medication on certain public and private school campuses.
Relating to a public school student's transition from an alternative education program to a regular educational environment, including parental rights related to that transition, and the admission of certain students with a criminal or disciplinary history.
Relating to evaluation under the state accountability system of school district campuses that enroll certain students who receive special education services.
Relating to the administration of opioid antagonists by a school nurse at public school campuses.
Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.